Investment analysts at StockNews.com assumed coverage on shares of Oragenics (NYSE:OGEN – Get Free Report) in a report issued on Saturday. The firm set a “sell” rating on the stock. Oragenics Stock ...

Dec. 16, 2024 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE: OGEN), a biotechnology company ... A and Series B Preferred Shares into common stock. The conversion helps simplify the company’s capital ...

Oragenics, Inc. has announced that its Chief Medical Officer, Dr. James P. Kelly, will participate as a panelist at the 12th Annual Brain Health Summit on February 8, 2025, coinciding with the ...

Elevate your confidence by analyzing investor sentiment and stock portfolio shifts, then make your own decisions.

Enhance your stock picks with dividend metrics like per-share dividends, yield, frequency, payout ratios, and more.

SEC Filings provided by EDGAR Online, Inc.